CIBC Private Wealth Group
FBRX icon

CIBC Private Wealth Group’s Forte Biosciences FBRX Stock Holding History

CIBC Private Wealth Group’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-440
Closed -$370K – 959
2021
Q2 		$370K Sell
440
-267
-38% -$241K ﹤0.01% 858
2021
Q1 		$606K Hold
707
– – ﹤0.01% 768
2020
Q4 		$643K Hold
707
– – ﹤0.01% 730
2020
Q3 		$857K Hold
707
– – ﹤0.01% 586
2020
Q2 		$258K Buy
707
+267
+61% +$119K ﹤0.01% 581
2020
Q1 		$201K Buy
+440
New +$172K ﹤0.01% 802

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

CIBC Private Wealth Group's FBRX Position: Q3 2021 in Review

CIBC Private Wealth Group sold out of Forte Biosciences (FBRX) in Q3 2021, closing a stake of 440 shares — an estimated $370K sold.

CIBC Private Wealth Group first reported a position in FBRX in Q1 2020 and held it in 6 quarters. The position peaked at $857K in Q3 2020. 57 funds tracked by Wall St. Rank hold FBRX as of Q3 2021.

  • CIBC Private Wealth Group reported no remaining Forte Biosciences position as of Q3 2021 after selling out during the quarter.
  • CIBC Private Wealth Group sold 440 Forte Biosciences shares in Q3 2021, an estimated $370K.
  • CIBC Private Wealth Group first reported a position in Forte Biosciences in Q1 2020 and held it in 6 quarters.
  • CIBC Private Wealth Group's Forte Biosciences position peaked at $857K in Q3 2020.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2021.

Based on CIBC Private Wealth Group's 13F filing for Q3 2021, filed 12 Nov 2021.